SFE Investment Counsel’s CRISPR Therapeutics CRSP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $352K | Buy |
7,232
+725
| +11% | +$35.3K | 0.06% | 111 |
|
|
2025
Q1 | $221K | Buy |
6,507
+355
| +6% | +$12.1K | 0.04% | 134 |
|
|
2024
Q4 | $242K | Sell |
6,152
-160
| -3% | -$6.3K | 0.05% | 102 |
|
|
2024
Q3 | $297K | Buy |
6,312
+466
| +8% | +$21.9K | 0.06% | 108 |
|
|
2024
Q2 | $316K | Buy |
5,846
+203
| +4% | +$11K | 0.07% | 110 |
|
|
2024
Q1 | $385K | Buy |
5,643
+743
| +15% | +$50.6K | 0.09% | 107 |
|
|
2023
Q4 | $307K | Buy |
+4,900
| New | +$307K | 0.08% | 106 |
|